Yoshimi Arima

2.4k total citations
46 papers, 2.0k citations indexed

About

Yoshimi Arima is a scholar working on Oncology, Molecular Biology and Cell Biology. According to data from OpenAlex, Yoshimi Arima has authored 46 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 21 papers in Molecular Biology and 9 papers in Cell Biology. Recurrent topics in Yoshimi Arima's work include Cancer Cells and Metastasis (16 papers), Cancer-related Molecular Pathways (7 papers) and Epigenetics and DNA Methylation (6 papers). Yoshimi Arima is often cited by papers focused on Cancer Cells and Metastasis (16 papers), Cancer-related Molecular Pathways (7 papers) and Epigenetics and DNA Methylation (6 papers). Yoshimi Arima collaborates with scholars based in Japan, United States and France. Yoshimi Arima's co-authors include Hideyuki Saya, Mari Hosonaga, Ryo Sato, Takashi Semba, Yoichi Taya, Christian Bronner, Hidemi Hayashi, Toru Hirota, Toshiyoshi Fujiwara and Kazuharu Kai and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Cell Biology.

In The Last Decade

Yoshimi Arima

46 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yoshimi Arima Japan	27	1.2k	906	396	297	291	46	2.0k
Matthias Drosten Spain	22	1.4k 1.2×	777 0.9×	291 0.7×	254 0.9×	261 0.9×	43	2.0k
Constadina Arvanitis United States	11	1.3k 1.1×	637 0.7×	422 1.1×	241 0.8×	139 0.5×	21	1.9k
Aleksandra Franovic United States	18	1.3k 1.1×	600 0.7×	744 1.9×	289 1.0×	336 1.2×	38	2.0k
Angela Platt‐Higgins United Kingdom	24	1.5k 1.2×	724 0.8×	582 1.5×	217 0.7×	261 0.9×	42	2.2k
Lori S. Hart United States	19	1.1k 0.9×	527 0.6×	404 1.0×	356 1.2×	230 0.8×	27	1.8k
Jung-Sik Kim United States	26	1.5k 1.3×	596 0.7×	406 1.0×	232 0.8×	313 1.1×	45	2.2k
Venkateshwar A. Reddy United States	17	1.4k 1.2×	807 0.9×	289 0.7×	227 0.8×	237 0.8×	29	2.1k
Isabel Chu United States	11	1.1k 1.0×	1.0k 1.1×	346 0.9×	267 0.9×	213 0.7×	12	1.8k
Gianluca Sala Italy	24	1.1k 0.9×	761 0.8×	225 0.6×	153 0.5×	213 0.7×	64	1.9k
François Lehembre Switzerland	17	1.8k 1.5×	1.1k 1.2×	362 0.9×	391 1.3×	172 0.6×	26	2.5k

Countries citing papers authored by Yoshimi Arima

Since Specialization

Citations

This map shows the geographic impact of Yoshimi Arima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshimi Arima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshimi Arima more than expected).

Fields of papers citing papers by Yoshimi Arima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshimi Arima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshimi Arima. The network helps show where Yoshimi Arima may publish in the future.

Co-authorship network of co-authors of Yoshimi Arima

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshimi Arima. A scholar is included among the top collaborators of Yoshimi Arima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshimi Arima. Yoshimi Arima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sato, Ryo, Takashi Semba, Yusuke Tomita, et al.. (2021). TGFβ Signaling Activated by Cancer-Associated Fibroblasts Determines the Histological Signature of Lung Adenocarcinoma. Cancer Research. 81(18). 4751–4765. 42 indexed citations

Hosonaga, Mari, Hideyuki Saya, & Yoshimi Arima. (2020). Molecular and cellular mechanisms underlying brain metastasis of breast cancer. Cancer and Metastasis Reviews. 39(3). 711–720. 106 indexed citations

Hosonaga, Mari, Yoshimi Arima, Oltea Sampetrean, et al.. (2018). HER2 Heterogeneity Is Associated with Poor Survival in HER2-Positive Breast Cancer. International Journal of Molecular Sciences. 19(8). 2158–2158. 26 indexed citations

Sakai, Shigeki, Hiroyuki Nobusue, Oltea Sampetrean, et al.. (2018). Tranilast inhibits the expression of genes related to epithelial-mesenchymal transition and angiogenesis in neurofibromin-deficient cells. Scientific Reports. 8(1). 6069–6069. 14 indexed citations

Sato, Ryo, Mari Hosonaga, Oltea Sampetrean, et al.. (2017). RNA Sequencing Analysis Reveals Interactions between Breast Cancer or Melanoma Cells and the Tissue Microenvironment during Brain Metastasis. BioMed Research International. 2017. 1–10. 29 indexed citations

Umeyama, Kazuhiro, Kota Watanabe, Masahito Watanabe, et al.. (2016). Generation of heterozygous fibrillin-1 mutant cloned pigs from genome-edited foetal fibroblasts. Scientific Reports. 6(1). 24413–24413. 33 indexed citations

Takenouchi, Toshiki, Chiharu Torii, Atsushi Shimizu, et al.. (2014). The Use of Next-Generation Sequencing in Molecular Diagnosis of Neurofibromatosis Type 1: A Validation Study. Genetic Testing and Molecular Biomarkers. 18(11). 722–735. 30 indexed citations

Kai, Kazuharu, Takayuki Iwamoto, Takashi Kobayashi, et al.. (2013). Ink4a/Arf−/− and HRAS(G12V) transform mouse mammary cells into triple-negative breast cancer containing tumorigenic CD49f− quiescent cells. Oncogene. 33(4). 440–448. 8 indexed citations

Arima, Yoshimi, Hidemi Hayashi, Mikako Sasaki, et al.. (2012). Induction of ZEB Proteins by Inactivation of RB Protein Is Key Determinant of Mesenchymal Phenotype of Breast Cancer. Journal of Biological Chemistry. 287(11). 7896–7906. 64 indexed citations

10.

Arima, Yoshimi, Naoki Hayashi, Hidemi Hayashi, et al.. (2011). Loss of p16 expression is associated with the stem cell characteristics of surface markers and therapeutic resistance in estrogen receptor‐negative breast cancer. International Journal of Cancer. 130(11). 2568–2579. 59 indexed citations

11.

Kai, Kazuharu, Osamu Nagano, Eiji Sugihara, et al.. (2009). Maintenance of HCT116 colon cancer cell line conforms to a stochastic model but not a cancer stem cell model. Cancer Science. 100(12). 2275–2282. 45 indexed citations

12.

Kai, Kazuharu, Yoshimi Arima, Toshio Kamiya, & Hideyuki Saya. (2009). Breast cancer stem cells. Breast Cancer. 17(2). 80–85. 77 indexed citations

13.

Arima, Yoshimi, Yasumichi Inoue, Tatsuhiro Shibata, et al.. (2008). Rb Depletion Results in Deregulation of E-Cadherin and Induction of Cellular Phenotypic Changes that Are Characteristic of the Epithelial-to-Mesenchymal Transition. Cancer Research. 68(13). 5104–5112. 131 indexed citations

14.

Bronner, Christian, Mayada Achour, Yoshimi Arima, et al.. (2007). The UHRF family: Oncogenes that are drugable targets for cancer therapy in the near future?. Pharmacology & Therapeutics. 115(3). 419–434. 141 indexed citations

15.

Kuninaka, Shinji, Hideaki Naoe, Masayuki Nitta, et al.. (2006). Serine protease Omi/HtrA2 targets WARTS kinase to control cell proliferation. Oncogene. 26(17). 2395–2406. 30 indexed citations

16.

Kuninaka, Shinji, Toru Hirota, Shin-ichi Iida, et al.. (2005). The tumor suppressor WARTS activates the Omi / HtrA2-dependent pathway of cell death. Oncogene. 24(34). 5287–5298. 35 indexed citations

17.

Arima, Yoshimi, Masayuki Nitta, Shinji Kuninaka, et al.. (2005). Transcriptional Blockade Induces p53-dependent Apoptosis Associated with Translocation of p53 to Mitochondria. Journal of Biological Chemistry. 280(19). 19166–19176. 128 indexed citations

18.

Honda, Shinobu, Tomotoshi Marumoto, Toru Hirota, et al.. (2004). Activation of m-Calpain Is Required for Chromosome Alignment on the Metaphase Plate during Mitosis. Journal of Biological Chemistry. 279(11). 10615–10623. 34 indexed citations

19.

Arima, Yoshimi, Toru Hirota, Christian Bronner, et al.. (2004). Down‐regulation of nuclear protein ICBP90 by p53/p21^Cip1/WAF1‐dependent DNA‐damage checkpoint signals contributes to cell cycle arrest at G1/S transition. Genes to Cells. 9(2). 131–142. 122 indexed citations

20.

Nitta, Masayuki, Hiromasa Tsuiki, Yoshimi Arima, et al.. (2002). Hyperploidy induced by drugs that inhibit formation of microtubule promotes chromosome instability. Genes to Cells. 7(2). 151–162. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact